2238 Merli, Geno S. - Thomas Jefferson University - Thomas Jefferson University
gjm101

Geno J. Merli, MD

Contact Dr Merli

111 S. 11th Street
Gibbon Building, Ste. 6270
Philadelphia, PA 19107

(215) 955-6540
(215) 923-0835 fax

Most Recent Peer-reviewed Publications

  1. Predicting the risk of venous thromboembolism in patients hospitalized with heart failure
  2. The Consult Guys - atrial fibrillation: how controlled is well-controlled?
  3. The Consult Guys - NPO before surgery: how long?
  4. The consult guys - surgery with a prosthetic valve: what about the warfarin?
  5. The Consult Guys--blindness after surgery: can you see the answer?
  6. D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: A subanalysis of the randomized controlled MAGELLAN trial
  7. The consult guys: hyperglycemia: am I a control freak?
  8. Evaluation of the oral direct factor Xa inhibitor-betrixaban
  9. The consult guys: green urine?!?
  10. Venous thromboembolism prevention guidelines for medical inpatients: Mind the (implementation) Gap
  11. The consult guys: perioperative risk assessment: can you get it right?
  12. The consult guys: a 23-year-old with a myocardial infarction: will you get the right diagnosis?
  13. Erratum: Implications of new anticoagulants in primary practice (Psycho-Oncology (2013) 67 (139-156))
  14. New oral anticoagulants: Prevention of VTE in phase III studies in total joint replacement surgery and the hospitalized medically-ill patients
  15. Deep Vein Thrombosis
  16. Delivery of optimized inpatient anticoagulation therapy: Consensus statement from the anticoagulation forum | Terapia de anticoagulación optimizada en el paciente hospitalizado: Declaración de consenso del Foro de Anticoagulación
  17. Novel anticoagulant use for venou 055E s thromboembolism: A 2013 update
  18. Rivaroxaban for thromboprophylaxis in acutely ill medical patients
  19. Implications of new anticoagulants in primary practice
  20. Implementing the new oral anticoagulants into the hospital formulary
0